Literature DB >> 30261329

Intrafraction Motion Management of Renal Cell Carcinoma With Magnetic Resonance Imaging-Guided Stereotactic Body Radiation Therapy.

Fieke M Prins1, Bjorn Stemkens2, Linda G W Kerkmeijer2, Maurits M Barendrecht3, Hans J de Boer2, Evert-Jan P A Vonken4, Jan J W Lagendijk2, Rob H N Tijssen2.   

Abstract

PURPOSE: One of the major challenges in stereotactic body radiation therapy (SBRT) of renal cell carcinoma is internal motion during treatment. Previous literature has aimed to mitigate the effects of motion by expanding the treatment margins or respiratory tracking. Online magnetic resonance imaging (MRI)-guided radiation therapy has the potential to further improve the treatment of renal cell carcinoma by direct visualization of the tumor during treatment. The efficacy of 2 motion management techniques were assessed: tumor trailing and respiratory tracking. The simulation of a single-fraction, MRI-based SBRT was performed to quantify intrafraction motion and assess the efficacy of the different motion management strategies. METHODS AND MATERIALS: Fifteen patients were included in the study. At the beginning and end of the scanning protocol, 2 cine-MRI scans were acquired to assess cyclic respiratory motion. In addition, 3-dimensional spoiled gradient echo scans were acquired at 4 different time points to assess the slow drifts over 25 minutes. The systematic and random errors owing to intrafraction drift were calculated, as well as the random error induced by respiratory motion. The motion margins were calculated for tumor trailing and respiratory tracking and compared with the margin when no motion compensation would be performed to assess the relative efficacy of each technique.
RESULTS: The largest respiratory tumor motion was observed along the caudo-cranial direction with a median 95% maximum amplitude of approximately 12 mm. ΣDRIFT, σDRIFT, and σRESP were determined to be 1.0 mm 1.8 mm, and 3.8 mm, respectively. Without mechanical immobilization, intrafraction drift accounted for 75% of the total intrafraction motion margin for online midposition-based SBRT treatments.
CONCLUSIONS: The contribution of intrafraction drift to the total internal motion margin is much larger than periodic respiratory motion. This makes tumor trailing a viable option to consider on the MRI linac because it allows for 3-dimensional MRI acquisitions during beam delivery, which simplifies the introduction of new techniques, such as dose accumulation and online intrafraction replanning.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2018        PMID: 30261329     DOI: 10.1016/j.prro.2018.09.002

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  5 in total

1.  Assessing organ at risk position variation and its impact on delivered dose in kidney SABR.

Authors:  Mathieu Gaudreault; Shankar Siva; Tomas Kron; Nicholas Hardcastle
Journal:  Radiat Oncol       Date:  2022-06-27       Impact factor: 4.309

Review 2.  Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research.

Authors:  Eugenia Vlaskou Badra; Michael Baumgartl; Silvia Fabiano; Aurélien Jongen; Matthias Guckenberger
Journal:  Transl Lung Cancer Res       Date:  2021-04

3.  Clinical workflow for treating patients with a metallic hip prosthesis using magnetic resonance imaging-guided radiotherapy.

Authors:  Rick Keesman; Erik van der Bijl; Tomas M Janssen; Tineke Vijlbrief; Floris J Pos; Uulke A van der Heide
Journal:  Phys Imaging Radiat Oncol       Date:  2020-08-12

4.  Intrafraction pancreatic tumor motion patterns during ungated magnetic resonance guided radiotherapy with an abdominal corset.

Authors:  Guus Grimbergen; Hidde Eijkelenkamp; Hanne D Heerkens; Bas W Raaymakers; Martijn P W Intven; Gert J Meijer
Journal:  Phys Imaging Radiat Oncol       Date:  2021-12-21

Review 5.  Patient positioning and immobilization procedures for hybrid MR-Linac systems.

Authors:  Francesco Cuccia; Filippo Alongi; Claus Belka; Luca Boldrini; Juliane Hörner-Rieber; Helen McNair; Michele Rigo; Maartje Schoenmakers; Maximilian Niyazi; Judith Slagter; Claudio Votta; Stefanie Corradini
Journal:  Radiat Oncol       Date:  2021-09-20       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.